Sab Biotherapeutics, Inc. · NASDAQ:SABS

Millennium Management LLC reported a 5.10% stake in Sab Biotherapeutics, Inc. (Schedule 13G)

Event Apr 24, 2026 · Filed May 1, 2026

Millennium Management LLC reported a 5.10% stake in Sab Biotherapeutics, Inc., 3,432,153 shares, as a passive investor on Apr 24, 2026. Filed May 1, 2026 (Schedule 13G).

Stake
5.10%
Shares
3,432,153
Intent
Passive
What changed
Crossed above 5%
Filed together
3 holders

The filing in full

HolderStakeShares
Millennium Management LLC5.10%3,432,153
Millennium Group Management LLC5.10%3,432,153
Israel A. Englander5.10%3,432,153

Source

View original at SEC

Related